TY - JOUR
T1 - Maternal circulating miRNAs that predict infant FASD outcomes influence placental maturation
AU - Collaborative Initiative on Fetal Alcohol Spectrum Disorders
AU - Tseng, Alexander M.
AU - Mahnke, Amanda H.
AU - Wells, Alan B.
AU - Salem, Nihal A.
AU - Allan, Andrea M.
AU - Roberts, Victoria H.J.
AU - Newman, Natali
AU - Walter, Nicole A.R.
AU - Kroenke, Christopher D.
AU - Grant, Kathleen A.
AU - Akison, Lisa K.
AU - Moritz, Karen M.
AU - Chambers, Christina D.
AU - Miranda, Rajesh C.
N1 - Funding Information:
This research was supported by grants from the NIH, P50 AA022534 (AM Allan), U01 AA014835 and the Office of Dietary Supplements (CD Chambers), R24 AA019431 (KA Grant), R01 AA021981 (CD Kroenke), R01 AA024659 (RC Miranda), and F31 AA026505 (AM Tseng). We thank the National Health and Medical Research Council of Australia (KM Moritz) for their support. We thank CIFASD for intellectual support and Megan S Pope and Tenley E Lehman for their assistance in conducting cell culture and animal studies. Data on human subjects are deposited at CIFASD.org, in accordance with NIH data repository guidelines.
Publisher Copyright:
© 2019 Tseng et al.
PY - 2019
Y1 - 2019
N2 - Prenatal alcohol exposure (PAE), like other pregnancy complications, can result in placental insufficiency and fetal growth restriction, although the linking causal mechanisms are unclear. We previously identified 11 gestationally elevated maternal circulating miRNAs ( HEa miRNAs) that predicted infant growth deficits following PAE. Here, we investigated whether these HEa miRNAs contribute to the pathology of PAE, by inhibiting trophoblast epithelial mesenchymal transition (EMT), a pathway critical for placental development. We now report for the first time that PAE inhibits expression of placental pro-EMT pathway members in both rodents and primates, and that HEa miRNAs collectively, but not individually, mediate placental EMT inhibition. HEa miRNAs collectively, but not individually, also inhibited cell proliferation and the EMT pathway in cultured trophoblasts, while inducing cell stress, and following trophoblast syncytialization, aberrant endocrine maturation. Moreover, a single intravascular administration of the pooled murine-expressed HEa miRNAs, to pregnant mice, decreased placental and fetal growth and inhibited the expression of pro-EMT transcripts in the placenta. Our data suggest that HEa miRNAs collectively interfere with placental development, contributing to the pathology of PAE, and perhaps also, to other causes of fetal growth restriction.
AB - Prenatal alcohol exposure (PAE), like other pregnancy complications, can result in placental insufficiency and fetal growth restriction, although the linking causal mechanisms are unclear. We previously identified 11 gestationally elevated maternal circulating miRNAs ( HEa miRNAs) that predicted infant growth deficits following PAE. Here, we investigated whether these HEa miRNAs contribute to the pathology of PAE, by inhibiting trophoblast epithelial mesenchymal transition (EMT), a pathway critical for placental development. We now report for the first time that PAE inhibits expression of placental pro-EMT pathway members in both rodents and primates, and that HEa miRNAs collectively, but not individually, mediate placental EMT inhibition. HEa miRNAs collectively, but not individually, also inhibited cell proliferation and the EMT pathway in cultured trophoblasts, while inducing cell stress, and following trophoblast syncytialization, aberrant endocrine maturation. Moreover, a single intravascular administration of the pooled murine-expressed HEa miRNAs, to pregnant mice, decreased placental and fetal growth and inhibited the expression of pro-EMT transcripts in the placenta. Our data suggest that HEa miRNAs collectively interfere with placental development, contributing to the pathology of PAE, and perhaps also, to other causes of fetal growth restriction.
UR - http://www.scopus.com/inward/record.url?scp=85065698831&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065698831&partnerID=8YFLogxK
U2 - 10.26508/lsa.201800252
DO - 10.26508/lsa.201800252
M3 - Article
C2 - 30833415
AN - SCOPUS:85065698831
SN - 2575-1077
VL - 2
JO - Life Science Alliance
JF - Life Science Alliance
IS - 2
M1 - e201800252
ER -